BRAIN METASTASES FROM SOLID TUMORS
Clinical trials for BRAIN METASTASES FROM SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new BRAIN METASTASES FROM SOLID TUMORS trials appear
Sign up with your email to follow new studies for BRAIN METASTASES FROM SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat HER2 cancers, including brain spread
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …
Matched conditions: BRAIN METASTASES FROM SOLID TUMORS
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial targets Tough-to-Treat cancers that spread to the brain
Disease control Recruiting nowThis is the first study in people to test a new experimental drug called AO-252. The main goal is to find a safe dose and check for side effects in adults with advanced solid tumors that have stopped responding to standard treatments, including cancers that may have spread to the…
Matched conditions: BRAIN METASTASES FROM SOLID TUMORS
Phase: PHASE1 • Sponsor: A2A Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New scan aims to spot hidden brain cancer recurrence
Diagnosis Recruiting nowThis study is testing a new imaging agent called RAD101 for PET scans. The goal is to see if it can better identify when brain tumors from common cancers like lung or breast cancer have returned after previous radiation treatment. About 30 adults who are suspected of having recur…
Matched conditions: BRAIN METASTASES FROM SOLID TUMORS
Phase: PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC